About InSymbiosis
InSymbiosis is a company based in Montreal (Canada) founded in 2005 was acquired by Camargo Pharma Services in June 2019.. InSymbiosis operates in a competitive market with competitors including EctoPharma, PharmaDirections, Novateur, Harte Group and Huperion, among others.
- Headquarter Montreal, Canada
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
- Investors
-
Employee Count
Employee Count
-
Acquired by
Camargo Pharma Services
(Jun 13, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of InSymbiosis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in InSymbiosis
InSymbiosis has secured backing from 1 investor. Prominent investors backing the company include Camargo Pharma Services. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Drug development solutions are provided from preclinical to commercialization stages.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by InSymbiosis
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - InSymbiosis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Insymbiosis Comparisons
Competitors of InSymbiosis
InSymbiosis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as EctoPharma, PharmaDirections, Novateur, Harte Group and Huperion, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Develops innovative technologies for creating therapeutic pharmaceutical products.
|
|
| domain | founded_year | HQ Location |
Offers expert virtual services in drug development and management for small biotech firms.
|
|
| domain | founded_year | HQ Location |
A virtual team of experts providing drug and device development services.
|
|
| domain | founded_year | HQ Location |
Provides vendor oversight, team support, patient recruitment, and site management for trials.
|
|
| domain | founded_year | HQ Location |
A pharmaceutical consulting and project management company.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Insymbiosis
Frequently Asked Questions about InSymbiosis
When was InSymbiosis founded?
InSymbiosis was founded in 2005.
Where is InSymbiosis located?
InSymbiosis is headquartered in Montreal, Canada. It is registered at Montreal, Quebec, Canada.
What does InSymbiosis do?
Insymbiosis is a virtual CRO offering customised drug development services to drug developers. The company has the capabilties to offer a one-stop shop solution that encompasses services for drug discovery, bioanalysisanalysis, drug safety assessment, chemistry, manufacture and control and clinical development. Their drug development engine model consists of 4 main components - a global network of CROs, a team of drug developers, an integrated infrastructure to facilitate clinical trial and quality management and an investment fund built by uniquely leveraging the RD tax environments of Canada and certain EU countries. Through the above components, they help their customers in accelerating their drugs development, while trying to keep costs and risks low. Insymbiosis operates mainly via 2 business models - the functional outsourcing model (where only a part of the development program like toxicology studies is outsourced) and a fully managed drug development model, wherein all aspects are outsourced). They claim to have served over 60 global biotech and pharma companies, and start up to early stage companies in their drug development pipeline. They also offer tailored solutions to meet the drug development needs of life science VCs and academic institutions.
Who are the top competitors of InSymbiosis?
InSymbiosis's top competitors include EctoPharma, PharmaDirections and Novateur.
Who are InSymbiosis's investors?
InSymbiosis has 1 investor. Key investors include Camargo Pharma Services.